Evidence map›Paper›PMID 41159798›Full record

Observational studyJournal of clinical microbiology2025

Sensitivity and specificity of the Cobas Liat CT/NG/MG nucleic acid test in a clinical laboratory setting and point-of-care location.

B Van Der Pol, R Arcenas, C Boraas, S Chavoustie, L L Crane, N d'Empaire, A C Ermel, G Harnett, F Hinestrosa, S House and 6 more

Abstract readMulticenter StudyObservational Study
In one paragraph

Observational study in Journal of clinical microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Point-of-care Tests for Chlamydia trachomatis and Neisseria gonorrhoeae: Review of the Literature.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2026
    Pooled it
  2. Guidelines and Diagnostic Assays forOpen forum infectious diseases · 2026
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

B Van Der PolUniversity of Alabama at Birmingham Heersink School of Medicine, Birmingham, Alabama, USA.ORCID 0000-0003-3064-8564
R ArcenasRoche Molecular Systems, Pleasanton, California, USA.
C BoraasPlanned Parenthood North Central States, Saint Paul, Minnesota, USA.
S ChavoustieSegal Trials North Miami Office, North Miami, Florida, USA.
L L CranePlanned Parenthood Gulf Coast, Houston, Texas, USA.
N d'EmpaireBioCollections Worldwide, Inc., Miami, Florida, USA.
A C ErmelIndiana University School of Medicine, Indianapolis, Indiana, USA.
G HarnettNo Resistance Consulting Group, LLC, Birmingham, Alabama, USA.
F HinestrosaOrlando Immunology Center, Orlando, Florida, USA.
S HouseWashington University School of Medicine, St. Louis, Missouri, USA.
R A LillisHenry Ford Hospital, Detroit, Michigan, USA.ORCID 0009-0008-6482-9084
J MillerMills Clinical Research, Los Angeles, California, USA.
A MillsNorth Jersey Community Research Initiative, Newark, New Jersey, USA.
R PobleteTriCore Reference Laboratories, Albuquerque, New Mexico, USA.
S A YoungLouisiana State University Health Sciences Center, New Orleans, Louisiana, USA.
Liat CT/NG/MG Clinical Trial Study Group

Funding

Roche Molecular Systems N/A
6 · The paper itself

Abstract

Sexually transmitted infections, e.g.,

Indexed as

Chlamydia InfectionsGonorrheaMolecular Diagnostic TechniquesMycoplasma InfectionsNucleic Acid Amplification TechniquesPoint-of-Care SystemsSexually Transmitted DiseasesAdolescentAdultChlamydia trachomatisFemaleHumansMaleMiddle AgedMycoplasma genitaliumNeisseria gonorrhoeaeChlamydia trachomatisCobas LiatMycoplasma genitaliumNeisseria gonorrhoeaenucleic acid testingpoint-of-care

Identifiers

PMID41159798
PMCPMC12710341

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.